Generics 36

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Azacitidine manufacturers

36 products found

Filters

36 products found

azacitidine

Powder and solvent for solution for injection/infusion 100 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply
Comments
RLD: Vidaza (Celgene). No solvent in the product.
Manufacturer #19992
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products for 190+ years. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are GMP-compliant. Main therapy areas include anti-infectives, dermatology, and CNS. The company products are prepared in CTD dossier format.

Manufacturer usually replies in 6 days

azacitidine

Powder for solution for injection 25mg/ml - 4 ml, 6 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #614
A pharmaceutical manufacturer based in Europe selling its products in Europe and worldwide for 10+ years. Main dosage forms include injectable and oral dosage forms. The company's production lines are EU GMP-compliant. The main therapeutic area is oncology.

Manufacturer usually replies in 7 days

azacitidine

Powder for solution for injection 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #12922

Manufacturer usually replies in 7 days

azacitidine

Tablets 200 mg, 300 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21467

Manufacturer usually replies in 9 days

azacitidine

Vials, lyophilized injection 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #17047
A pharmaceutical manufacturer based in the EU that sells its products in Europe, the Middle East, CIS, LATAM, and Asia. Key production lines are pharmaceuticals, bio and nanopharmaceuticals, medical devices, and nutraceuticals. The main therapeutic area is oncology.

Manufacturer usually replies in 10 days

azacitidine

Vials, injection 100mg/25.5ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Spain , Germany , Sweden , Finland , Norway , Ireland
Registered in
United Kingdom
Manufacturer #9300

Manufacturer usually replies in 3 days

azacitidine

Solution for injection 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica , United Kingdom
Manufacturer #1338

Manufacturer usually replies in 7 days

azacitidine

Tablets 200 mg, 300 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica
Manufacturer #1338

Manufacturer usually replies in 7 days

azacitidine

Vials, injection 100mg/10ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13291

Manufacturer usually replies in 6 days

azacitidine

Vials, injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17708

Manufacturer usually replies in 4 days

azacitidine

Solution for injection 100mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #8228

Manufacturer usually replies in 2 days

azacitidine

Injection, lyophilized 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 5 days

azacitidine

Vials, injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

azacitidine

Vials, injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, ANVISA
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

azacitidine

Injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

azacitidine

Powder for solution for injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20530
With the rapid improvement of pharmaceutical technology and the approaching aging society, they focus on the development of innovative healthcare technology for Acute and Critical Care and Anti-aging and Preventive Medicine. The company has passed US FDA, Japan PMDA, and PIC/S GMP inspections through specific approaches to total quality management.

Manufacturer usually replies in 2 days

azacitidine

Vials, lyophilized injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17902
The commitment of the company for more than 25 years has been to improve ourselves day by day to provide medicines that allow everyone to enjoy a better quality of life. Production based on international standards and an industrial complex equipped with the highest technology ensure the quality of the medicines.

Manufacturer usually replies in 3 days

azacitidine

Vials, injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
WHO
Manufacturer #15160

Manufacturer usually replies in 5 days

azacitidine

Vials, injection 100MG

Dossier type
CTD
Dossier status
Under development
Country of origin
India
Manufacturer #13085

Manufacturer usually replies in 4 days

azacitidine

Solution for injection 0.1g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #13622

Manufacturer usually replies in 6 days

Want to view all 36 products? Create your free account today!

AZACITIDINE manufacturer

Azacitidine is a medicine composed of a chemical analog of the nucleoside cytidine and is predominantly used for the treatment of myelodysplastic syndrome. Approved in the United States by the FDA in 2004 for commercial manufacturers and distributors, it was initially synthesized in Czechoslovakia for use as a chemotherapy agent, with the original Investigational New Drug application being submitted by the National Cancer Institute in 1971. Currently, it is listed both for sale and wholesale by multiple azacitidine manufacturers and azacitidine suppliers on the global marketplace. Where it is sold at a diversity of different price points by global distributors under brand names including Vidaza and Onureg. As a generic pharmaceutical product, azacitidine does not require specialized licensing agreements to commercialization nor duplicate, and so presents as a cost-effective and attractive option to manufacturers and distributors. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking AZACITIDINE: You should not use This medical remedy if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide.

How Does AZACITIDINE Work?

Belonging to a group of pharmaceutical products which are chemical analogs to the cytidine nucleoside used in DNA and RNA, it is thought that azacitidine induces antineoplastic activity through the functional inhibition of the DNA methyltransferase enzyme at low doses and causes cytotoxicity at high doses through incorporation into RNA and DNA. Preventing DNA syntheses by resulting in hypermethylation of the DNA through covalent bonding to DNA methyltransferase. Due to azacitidine being a ribonucleoside, it has a higher affinity for RNA than DNA, inducing relatively elevated incorporation into RNA. This results in disassembly of polyribosomes, defective methylation, and acceptor function of transfer RNA, culminating in inhibition of protein production and subsequent cell death.

How to use AZACITIDINE

Read the AZACITIDINE Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking AZACITIDINE. If you have any questions related to AZACITIDINE, ask your pharmacist or doctor. The final form of this medication is dependent on the judgment of both azacitidine manufacturers and azacitidine suppliers. However, it is typically found for sale and wholesale as vials, lyophilized vials, solutions for injections, and a solution for infusion. As a prescribed product, the administration is strictly done under the guise of a medical professional. With treatments typically done in a cycle of once a day for a weeklong duration, followed by three weeks of no treatment. This however is tailored to the specific needs and medical response of the individual, as such many variations in dose and treatment cycles exist and are prescribed. It is advised to take this azacitidine by mouth with or without food as directed by your health care instructor, usually once or twice daily. The dosage is based on your physical or mental condition and response to medication. Tell your health care instructor if you do not get better or if you get worse.

How much money does AZACITIDINE cost?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The cost for AZACITIDINE 100 mg is around $112. Prices may vary on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of AZACITIDINE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for AZACITIDINE manufacturers and AZACITIDINE suppliers that you are looking for. These also enable you to check the dossier status of AZACITIDINE, and the GMP approvals of the different variants of AZACITIDINE. Also, each manufacturer or supplier product description contains essential information about AZACITIDINE including clinical data, stability zones, countries where AZACITIDINE is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.